Determinants of autonomic dysfunction in idiopathic Parkinson’s disease
To determine demographic or disease-related factors that may influence the severity of autonomic dysfunction in idiopathic Parkinson’s disease (IPD).
532 patients with IPD aged between 55 and 75 years were included. Severity of autonomic dysfunction was assessed using a 9-item autonomic dysfunction score (ADS). In addition, several demographic factors (e. g. age, gender, comorbidities) and disease- related (e. g. motor stage, disease duration, antiparkinsonian therapy) factors were recorded. A group of 67 age-matched healthy volunteers served as a control group. Demographic and clinical data of this cross-sectional survey were analyzed by a logistic stepwise regression model to determine independent predictors of autonomic dysfunction.
IPD patients showed significantly higher ADS values than controls, even in the youngest age groups and in mild disease stages. Hoehn&Yahr (H&Y) stage, disease duration, age at onset and various therapy combinations all showed significant correlations with ADS. However, stepwise logistic regression revealed that age (OR 10.71; CI 7.17–16.0) and arterial hypertension (OR 3.05; CI 1.66–5.58) were the only independent risk factors associated with autonomic dysfunction. Linear regression indicated that ADS increases with age in controls as well as in patients, but with a significantly steeper slope in the latter.
Autonomic dysfunction as an inherent feature of IPD is present already in early disease stages. According to a logistic regression model, the severity of autonomic dysfunction in IPD is primarily related to demographic but not to disease-related factors. This and the differences in predictors for motor versus autonomic decline may indicate at least partly independent neurodegenerative processes.
Key wordsParkinson’s disease autonomic dysfunction age risk factors drug treatment
Unable to display preview. Download preview PDF.
- 5.Braak H, Braak E (2000) Pathoanatomy of Parkinson’s disease. J Neurol 247 (Suppl 2):3–10Google Scholar
- 6.Braak H, Del Tredici K, Rüb U, et al. (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neuropathol Aging 24:197–211Google Scholar
- 8.Camerlingo M, Aillon C, Bottacchi E, et al. (1986) Parasympathetic assessment in Parkinson’s disease. Adv Neurol 45:267–269Google Scholar
- 9.Daniel SE, Lees AJ (1993) Parkinson’s Disease Society Brain Bank, London: Overview and Research. J Neural Transm 39(Suppl):165–172Google Scholar
- 12.Fahn S, Elton RL, and members of the UPDRS development committee (1987) Unified Parkinson’s Disease rating scale. In: Fahn S, Marsden CD, Goldstein M (eds) Recent development in Parkinson’s disease II. McMillan, New York, pp 153–163Google Scholar
- 23.Korczyn AD (1989) Autonomic nervous system screening in patients with early Parkinson’s disease. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien, pp 41–48Google Scholar
- 29.Martignoni E, Micieli G, Cavallini A, et al. (1986) Autonomic disorders in idiopathic Parkinsonism. J Neural Transm 22(Suppl):149–161Google Scholar
- 30.Martignoni E, Pacchetti C, Godi L, Micieli G, Nappi G (1995) Autonomic disorders in Parkinson’s disease. J Neural Transm 45(Suppl):11–19Google Scholar
- 33.Olanow CW, Watts RL, Koller WC (2001) An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines. Neurology 56(Suppl 5):1–88Google Scholar
- 35.Pacchetti C, Sibilla L, Bruggi P, et al. (1990) Autonomic disturbances in Parkinson’s disease and Multisystem Atrophy: Clinical aspects. Funct Neurol 5(Suppl 4):49–56Google Scholar